Effects of antidepressants and benzodiazepine-type anxiolytic agents on hepatic porphyrin accumulation in primary cultures of chick embryo liver cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1150-1155

  Lambrecht, Richard W ^a,b   Gildemeister, Otto S ^a,b   Pepe, Joyce A ^a,b   Tortorelli, Kristina D ^a,b   Williams, Alyssa ^b   Bonkovsky, Herbert L ^a,b,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Ctr Stud Disord Iron Porphyrin M   (United States)

^c Division of Digestive Disease and Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; FLUOXETINE; LORAZEPAM; MIDAZOLAM; NEFAZODONE; OXAZEPAM; PAROXETINE; PORPHYRIN; TRIAZOLAM;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CHICK EMBRYO; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMBRYO; LIVER CELL CULTURE; NONHUMAN; PORPHYRIA; PRIORITY JOURNAL;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; CELLS, CULTURED; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; PORPHYRIAS; PORPHYRINS; PROTEINS;

EID: 0032747790     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ades IZ and Harpe KG (1981) Biogenesis of mitochondrial proteins. Identification of the mature and precursor forms of the subunit of δ-aminolevulinate synthase from embryonic chick liver. J Biol Chem 256:9329-9333.
2. Aranda-Michel J, Koeller A, Bejarano PA, Poulos JE, Luxon BA, Khan CM, Ee LC, Balistreri WF and Weber FL Jr (1999) Nefazodone-induced liver failure: Report of three cases. Ann Intern Med 130:285-288.
3. Ashley EMC (1996) Anaesthesia for porphyria. Br J Hosp Med 56:37-42.
4. Bonkovsky HL, Healey JF, Sinclair PK and Sinclair JF (1985) Conversion of 5-aminolevulinate into haem by homogenates of human liver: Comparison with rat and chick embryo liver homogenates. Biochem J 227:893-901.
5. Bonkovsky HL, Cable EE, Cable JW, Donohue SE, White EC, Greene YJ, Lambrecht RW, Srivastava KK and Arnold WN (1992) Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh). Biochem Pharmacol 43:2359-2368.
6. Cable EE, Gildemeister OS, Pepe JA, Donohue SE, Lambrecht RW and Bonkovsky HL (1996) Hepatic 5-aminolevulinic acid synthase mRNAstability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins. Eur J Biochem 240: 112-117.
7. Cable EE, Pepe JA, Donohue SE, Lambrecht RW and Bonkovsky HL (1994a) Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450 in cultured chick embryo liver cells, possible implications for acute porphyria. Eur J Biochem 225:651-657.
8. Cable EE, Pepe JA, Karamitsios NC, Lambrecht RW and Bonkovsky HL (1994b) Differential effects of metalloporphyrins on messenger RNA levels of δ-aminole-vulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells. J Clin Invest 94:649-654.
9. Catalano G, Catalano MC and Tumarkin NB (1999) Nefazodone overdose: A case report. Clin Neuropharmacol 22:63-65.
10. Dewan MJ and Anand VS (1999) Evaluating the tolerability of the newer antidepressants. J Nerv Ment Dis 187:96-101.
11. Deybach JC, Da Silva V, Phung LN, Levy JC and Nordmann Y (1987) Drug risk in hepatic porphyrias. Development of an experimental model. Presse Med 18:68-71.
12. Dover SB, Plenderleith L, Moore MR and McColl KEL (1994) Safety of general anaesthesia and surgery in acute hepatic porphyria. Gut 36:1112-1115.
13. Drew PD and Ades IZ (1989) Regulation of the stability of chicken embryo liver δ-aminolevulinate synthase mRNA by hemia. Biochem Biophys Res Commun 162:102-107.
14. Eales L (1979) Porphyria and the dangerous life-threatening drugs. S Afr Med J 56:914-917.
15. Goerz G, Bolsen K, Böhrer H, Fritsch C, Kalka K and Rominger KL (1997) Effects of clonidine in a primed rat model of acute hepatic porphyria. Arzneim Forsch 47:731-733.
16. Gorchein A (1997) Drug treatment in acute porphyria. Br J Clin Pharmacol 44:427-434.
17. Grandchamp B, Deybach JC, Grelier M, De Verneuil H and Nordmann Y (1980) Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic coproporphyria and one patient with homozygous coproporphyria. Biochim Biophys Acta 629:577-586.
18. Granick S (1966) The induction in vitro of the synthesis of 5-aminolevulinic acid synthetase in chemical porphyria: A response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem 241:1359-1375.
19. Hahn M and Bonkovsky HL (1998) Disorders of porphyrin metabolism, in Diseases of the Liver and Bile Ducts. A practical Guide to Diagnosis and Treatment (Wu GY and Israel J eds) pp. 249-272, Humana Press, Totowa, NJ.
20. Hahn M, Gildemeister OS, Krauss GL, Pepe JA, Lambrecht RW, Donohue S and Bonkovsky HL (1997) Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: Potential implications for patients with acute porphyria. Neurology 49:97-106.
21. Hamilton JW, Bernent WJ, Sinclair PR, Sinclair JF, Alcedo JA and Wetterhahn KE (1991) Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys 289:387-392.
22. Hamilton JW, Bernent WJ, Sinclair PR, Sinclair JF and Wetterhahn KE (1988) Expression of 5-aminolaevulinate synthase and cytochrome P-450 mRNAs in chicken embryo hepatocytes in vivo and in culture. Effect of porphyrinogenic drugs and haem [published erratum appears in Biochem J (1989) 257:934]. Biochem J 256:267-275.
23. Healey JF, Bonkowsky HL, Sinclair PR and Sinclair JF (1981) Conversion of 5-aminolevulinate into haem by liver homogenates: Comparison of rat and chick embryos. Biochem J 198:595-604.
24. Kalman DR and Bonkovsky HL (1998) Management of acute attacks in the porphyrias. Clin Dermatol 16:299-306.
25. Kappas A, Sassa S, Galbraith RA and Nordmann Y (1995) The Porphyrias, in The Metabolic Basis of Inherited Disease (Scriver CR, Beaudet AL, Sly WS and Valle D eds) 7th ed., pp 2103-2160, McGraw-Hill Book Company, New York.
26. Lathrop JT and Timko MP (1993) Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science (Wash DC) 259:522-525.
27. Lindberg RLP, Porcher C, Grandchamp B, Ledermann B, Bürki K, Brandner S, Aguzzi A and Meyer UA (1996) Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet 12:195-199.
28. Marks GS, Goldman DR, McClusky SA, Sutherland EP and Lyon ME (1986) The effects of dihydropyridine calcium antagonists on heme biosynthesis in chick embryo liver cell culture. Can J Physiol Pharmacol 64:438-443.
29. Marks GS, Powles J, Lyon M, McClusky S, Sutherland E and Zelt D (1987) Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents. Ann NYAcad Sci 514:113-127.
30. Moore MR (1980) International review of drugs in acute porphyria-1980. Int J Biochem 12:1089-1097.
31. Moore MR and Hift RJ (1997) Drugs in the acute porphyrias -Toxicogenetic diseases. Cell Mol Biol 43:89-94.
32. Moore MR and McColl KEL (1989) Therapy of the acute porphyrias. Clin Biochem 22:181-188.
33. Parikh RK and Moore MR (1978) Effect of certain anaesthetic agents on the activity of rat hepatic δ-aminolaevulinate synthase. Br J Anaesth 50:1009-1103.
34. Ryan G and Ades IZ (1989) Coordinate elevations of liver δ-aminolevulinate synthase and cytochrome P-450 RNA by phenobarbital in chicken embryos: The effects of heme. Int J Biochem 21:1025-1031.
35. Schoenfeld N, Aelion J, Beigel Y, Epstein O and Atsmon A (1985) The porphyrogenic effects of calcium channel blocking drugs. Clin Sci 69:581-586.
36. Settle EC Jr (1998) Bupropion sustained release: Side effect profile. J Clin Psychiatry 59:32-36.
37. Sinclair PR, Bernent WJ, Bonkovsky HL, Lambrecht RW, Frezza JE, Sinclair JF, Urquhart AJ and Elder GH (1986) Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide. Biochem J 237:63-71.
38. Tschudy DP and Bonkowsky HL (1972) Experimental porphyria. Fed Proc 31:147-159.
39. Vaz FJ and Salcedo MS (1991) Fluoxetine treatment of depressive symptoms in acute intermittent porphyria. J Clin Psychiatry 52:138.
40. Zimmer S, Taub H and Marks GS (1980) A comparison of the porphyrin-inducing activity of barbiturates and benzodiazepines in chick embryo liver cells. Can J Physiol Pharmacol 58:991-995.